Published on:
March 6, 2026
In a development that has significant implications for men's health across the nation, prostate cancer has officially overtaken breast cancer as the most commonly diagnosed cancer in the UK. NHS data confirms that the number of prostate cancer diagnoses has been higher than breast cancer for two consecutive years, marking a historic shift in the country's cancer landscape. With over 64,000 new cases diagnosed every year — roughly 175 every single day — this is no longer a disease that men can afford to ignore.
But experts say the rising numbers are not entirely bad news. Much of the increase is being driven by greater awareness and more men coming forward for testing, particularly following high-profile campaigns in the wake of the pandemic. The result is that thousands more men are receiving early, life-changing diagnoses at a stage when treatment is most effective. Understanding the risks, recognising the symptoms, and knowing when to seek prostate screening are now more important than ever.
The surge in prostate cancer diagnoses can be attributed to several converging factors. During the COVID-19 pandemic, routine health appointments were delayed or cancelled, creating a backlog of undiagnosed cases. As healthcare services resumed, a wave of men sought medical attention for symptoms they had been living with for months or even years. This catch-up effect accounts for a significant portion of the increased numbers.
Perhaps more encouragingly, awareness campaigns led by organisations such as Prostate Cancer UK have had a measurable impact. Celebrity endorsements, media coverage, and grassroots initiatives have prompted men — historically reluctant to visit the doctor — to request PSA (prostate-specific antigen) blood tests. According to Prostate Cancer UK, more men are now receiving lifesaving radical treatments, whilst the number of men with slow-growing disease who may receive unnecessary treatment has remained reassuringly low.
An ageing population also plays a role. Prostate cancer primarily affects men over the age of 50, and as the UK's male population lives longer, the absolute number of diagnoses naturally increases. Incidence rates in males have risen by almost 55% since the early 1990s, with a further 10% increase in the last decade alone, according to Cancer Research UK.
The prostate is a small, walnut-sized gland that sits below the bladder and surrounds the urethra in men. Its primary function is to produce seminal fluid, which nourishes and transports sperm. Because of its location, changes to the prostate — whether benign enlargement or cancerous growth — often affect urination and sexual function.
Prostate cancer occurs when cells in the prostate gland begin to grow abnormally and uncontrollably. It is often a slow-growing cancer, meaning many men live with it for years without experiencing symptoms. However, some forms of prostate cancer are aggressive and can spread to other parts of the body, including the bones and lymph nodes, making early detection critically important.
The disease accounts for over a quarter of all new male cancer cases in the UK, making it by far the most significant cancer threat men face. An estimated 540,000 men are currently living with or after a prostate cancer diagnosis in the UK, as reported by The Mirror. If you would like to learn more about the condition itself, our dedicated prostate cancer page provides a comprehensive overview of causes, stages, and treatment pathways.
Whilst any man can develop prostate cancer, certain groups face a significantly higher risk. Understanding these risk factors is the first step towards proactive health management.
Age is the single most significant risk factor. Prostate cancer is rare in men under 40, but the risk increases substantially after 50. Around three-quarters of cases are diagnosed in men over the age of 65. This does not mean younger men should be complacent — if you have other risk factors, earlier vigilance is warranted.
Men with a father or brother who had prostate cancer are approximately two to three times more likely to develop the disease themselves. The risk is even higher if the relative was diagnosed before the age of 60. Certain inherited gene mutations, including BRCA1 and BRCA2 (more commonly associated with breast cancer), also increase prostate cancer risk. Men with a strong family history may benefit from cancer genetic testing to better understand their personal risk profile.
Black men are disproportionately affected by prostate cancer. In the UK, approximately 1 in 4 Black men will be diagnosed with prostate cancer in their lifetime, compared with roughly 1 in 8 white men. Black men are also more likely to be diagnosed at a later stage and to develop more aggressive forms of the disease. This stark inequality underscores the urgent need for targeted awareness and screening programmes.
Whilst the link between lifestyle and prostate cancer is less clear-cut than with some other cancers, emerging evidence suggests that obesity, a diet high in processed foods, and a sedentary lifestyle may contribute to increased risk. Maintaining a healthy weight, exercising regularly, and eating a balanced diet rich in vegetables and whole grains are sensible steps for overall health and may offer some protective benefit.
One of the most challenging aspects of prostate cancer is that early-stage disease often produces no symptoms at all. This is precisely why screening is so important — by the time symptoms appear, the cancer may have progressed to a more advanced stage.
When symptoms do occur, they are often related to the prostate's proximity to the bladder and urethra. Common signs include:
It is important to note that many of these symptoms overlap with benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate that is very common in older men. However, overlapping symptoms should never be a reason to dismiss concerns. Any persistent change in urinary or sexual function warrants a conversation with your GP.
Leading urologists have been vocal about the need for men to overcome any embarrassment. As one prominent prostate cancer surgeon recently stated, the single most important thing men can do is request a PSA test and have an open conversation with their doctor — particularly if they are over 50, are Black, or have a family history of the disease.
The PSA (prostate-specific antigen) test is a simple blood test that measures the level of PSA in the blood. PSA is a protein produced by both normal and cancerous prostate cells, and elevated levels can indicate the presence of prostate cancer — though they can also be raised by infection, inflammation, or benign enlargement.
The PSA test is not perfect. It can produce false positives (suggesting cancer when none is present) and false negatives (missing cancer that is there). For this reason, the NHS does not currently offer a national screening programme for prostate cancer. However, any man over 50 can request a PSA test from their GP, and men in higher-risk groups are strongly encouraged to do so.
If a PSA test returns an elevated result, further investigations are typically recommended. These may include:
At Spital Clinic, our prostate screening service offers a thorough, personalised assessment that includes PSA testing and clinical evaluation. Early detection remains the single most powerful tool in improving outcomes, and men should not wait for symptoms to appear before seeking assessment.
The treatment landscape for prostate cancer has evolved considerably in recent years, offering men more options and better outcomes than ever before. The approach depends on several factors, including the stage and grade of the cancer, the patient's age, overall health, and personal preferences.
For men with low-risk, slow-growing prostate cancer, active surveillance may be the most appropriate course of action. This involves regular PSA tests, MRI scans, and sometimes biopsies to monitor the cancer closely without immediate treatment. The rationale is that many low-grade prostate cancers will never cause harm during a man's lifetime, and avoiding unnecessary treatment spares patients from potential side effects such as incontinence and erectile dysfunction.
Radical prostatectomy — the surgical removal of the entire prostate gland — is a common treatment for localised prostate cancer. Modern techniques, including robot-assisted surgery, have improved precision and reduced recovery times, though risks of urinary incontinence and sexual dysfunction remain.
External beam radiotherapy and brachytherapy (internal radiotherapy) are effective alternatives to surgery. Advances in targeted radiotherapy have reduced damage to surrounding healthy tissue, improving quality of life during and after treatment.
Hormone therapy, which reduces testosterone levels to slow cancer growth, is often used alongside other treatments, particularly for locally advanced or metastatic prostate cancer. It is worth noting that men undergoing hormone therapy may experience side effects that overlap with those of low testosterone. Our men's health GP service can help manage these broader health concerns alongside cancer treatment pathways.
For advanced prostate cancer, chemotherapy, targeted therapies, and newer immunotherapy options are also available. Survival rates have improved significantly: when diagnosed at an early stage, the five-year survival rate for prostate cancer in the UK exceeds 95%. Even for men with more advanced disease, treatments are extending life and preserving quality of life in ways that were not possible a generation ago.
The shift in prostate cancer's position to the UK's most common cancer is a wake-up call, but it should be a motivating one rather than a frightening one. Here are the practical steps every man can take today:
The message from leading clinicians is unequivocal: early detection saves lives. The fact that more men are coming forward for testing is genuinely positive — it means cancers are being caught earlier, treatments are more effective, and outcomes are improving year on year.
Most guidelines suggest that men should begin discussing prostate cancer screening with their GP from the age of 50. However, men who are Black or who have a first-degree relative (father or brother) diagnosed with prostate cancer should consider having this conversation from the age of 45. There is no one-size-fits-all approach, so an individualised risk assessment is recommended.
The PSA test is a useful initial screening tool, but it is not definitive on its own. Elevated PSA levels can be caused by conditions other than cancer, including benign prostate enlargement and infection. Equally, some men with prostate cancer may have normal PSA levels. When combined with clinical examination and, if necessary, MRI and biopsy, the PSA test forms part of a comprehensive diagnostic pathway that is highly effective at detecting clinically significant cancer.
The reasons are not fully understood, but research points to a combination of genetic factors. Studies have identified specific gene variants that are more common in men of African and Caribbean descent and that appear to increase susceptibility to prostate cancer. Black men are also more likely to be diagnosed with aggressive forms of the disease, which is why earlier and more regular screening is particularly important for this group.
There is currently no guaranteed way to prevent prostate cancer. However, maintaining a healthy weight, eating a diet rich in fruits and vegetables, exercising regularly, and limiting alcohol consumption may reduce your overall cancer risk. Most importantly, regular screening allows for early detection, which dramatically improves treatment outcomes and survival rates.
Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate that is very common in men over 50. It can cause urinary symptoms similar to those of prostate cancer, such as frequent urination and difficulty starting to urinate. Unlike prostate cancer, BPH does not spread to other parts of the body and is not life-threatening, though it can significantly affect quality of life. Only proper medical investigation can distinguish between the two conditions, which is another reason why seeking medical advice for urinary symptoms is so important.
The information provided in this article is for educational purposes only and is based on NHS recommendations. It is not a substitute for professional medical advice. Always consult your doctor or a qualified healthcare provider for advice on medical conditions or treatments.
Our medical centre is at 36 Spital Square, E1 6DY, City of London.
